Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome
31P Magnetic resonance spectroscopy studies were carried out in vivo on skeletal muscle of a patient with verapamil-responsive, chronic, progressive post-exertional muscle pain. A sister suffered from a similar complaint. The results showed that the muscle: (1) decreased its high energy phosphate co...
Gespeichert in:
Veröffentlicht in: | Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 1988-11, Vol.51 (11), p.1425-1433 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1433 |
---|---|
container_issue | 11 |
container_start_page | 1425 |
container_title | Journal of neurology, neurosurgery and psychiatry |
container_volume | 51 |
creator | Taylor, D J Brosnan, M J Arnold, D L Bore, P J Styles, P Walton, J Radda, G K |
description | 31P Magnetic resonance spectroscopy studies were carried out in vivo on skeletal muscle of a patient with verapamil-responsive, chronic, progressive post-exertional muscle pain. A sister suffered from a similar complaint. The results showed that the muscle: (1) decreased its high energy phosphate content more rapidly than normal during exercise, indicating either increased utilisation or decreased production of ATP; (2) acidified more rapidly than normal during exercise suggesting an increased glycolytic rate; (3) continued in some studies to acidify markedly during the first minute after exercise, indicating that glycolysis remained active into the recovery period; (4) had phosphocreatine and ADP recovery rates consistent with normal rates of oxidative phosphorylation. On the basis of these results, it was proposed that the patient suffers from a defect in Ca2+ handling in the muscle. Subsequently, direct measurement of Ca2+-ATPase activity in the sarcoplasmic reticulum fraction from a muscle biopsy sample showed that the activity of this enzyme was reduced by about 90%. |
doi_str_mv | 10.1136/jnnp.51.11.1425 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1032814</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78696168</sourcerecordid><originalsourceid>FETCH-LOGICAL-b3655-b9689f975fd0efa8b8bcfe5c8dec1cecf6bfb906f847ce579c4f7decc702b9b23</originalsourceid><addsrcrecordid>eNqFkUuLFDEUhYMoYzu6diUUKC6U6smj8toIY-N7UJF2cBeSVOKkpyrVJlU6_e9N0U2jbswmHM6Xy7k5ADxEcIkQYWebGLdLiopYogbTW2CBGiZqQuC322ABIcY1gRTeBfdy3sD5CHkCTrDkTCC4AB9WGj-vz9efdXZV63ywwUW7q0KsdLXVY1Fj9SuMV5WOlbtxaQxD1F3VT9l2rhAFzLvYpqF398Edr7vsHhzuU_D19av16m198enNu9X5RW0Io7Q2kgnpJae-hc5rYYSx3lErWmeRddYz442EzIuGW0e5tI3nxbMcYiMNJqfgxX7udjK9a22JmHSntin0Ou3UoIP624nhSn0ffioECRaoKQOeHgak4cfk8qj6kK3rOh3dMGXFBZMMMVHAx_-Am2FKZf-sEOek_C7HslBne8qmIefk_DEKgmpuSc0tKYqKUHNL5cWjPzc48odaiv_k4OtsdeeTjjbkI8Y4IqKZ49V7LOTR3Rxtna4LQjhVHy9X6nL9RfKX76ma-Wd73vSb_2b8DYecuMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1773022729</pqid></control><display><type>article</type><title>Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Taylor, D J ; Brosnan, M J ; Arnold, D L ; Bore, P J ; Styles, P ; Walton, J ; Radda, G K</creator><creatorcontrib>Taylor, D J ; Brosnan, M J ; Arnold, D L ; Bore, P J ; Styles, P ; Walton, J ; Radda, G K</creatorcontrib><description>31P Magnetic resonance spectroscopy studies were carried out in vivo on skeletal muscle of a patient with verapamil-responsive, chronic, progressive post-exertional muscle pain. A sister suffered from a similar complaint. The results showed that the muscle: (1) decreased its high energy phosphate content more rapidly than normal during exercise, indicating either increased utilisation or decreased production of ATP; (2) acidified more rapidly than normal during exercise suggesting an increased glycolytic rate; (3) continued in some studies to acidify markedly during the first minute after exercise, indicating that glycolysis remained active into the recovery period; (4) had phosphocreatine and ADP recovery rates consistent with normal rates of oxidative phosphorylation. On the basis of these results, it was proposed that the patient suffers from a defect in Ca2+ handling in the muscle. Subsequently, direct measurement of Ca2+-ATPase activity in the sarcoplasmic reticulum fraction from a muscle biopsy sample showed that the activity of this enzyme was reduced by about 90%.</description><identifier>ISSN: 0022-3050</identifier><identifier>EISSN: 1468-330X</identifier><identifier>DOI: 10.1136/jnnp.51.11.1425</identifier><identifier>PMID: 2976810</identifier><identifier>CODEN: JNNPAU</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd</publisher><subject>Adult ; Biological and medical sciences ; Calcium-Transporting ATPases - deficiency ; Diseases of striated muscles. Neuromuscular diseases ; Exercise Test ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Medical sciences ; Muscle Contraction - drug effects ; Muscle Cramp - drug therapy ; Muscle Cramp - enzymology ; Neurology ; Physical Exertion ; Verapamil - therapeutic use</subject><ispartof>Journal of neurology, neurosurgery and psychiatry, 1988-11, Vol.51 (11), p.1425-1433</ispartof><rights>1990 INIST-CNRS</rights><rights>Copyright BMJ Publishing Group LTD Nov 1988</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b3655-b9689f975fd0efa8b8bcfe5c8dec1cecf6bfb906f847ce579c4f7decc702b9b23</citedby><cites>FETCH-LOGICAL-b3655-b9689f975fd0efa8b8bcfe5c8dec1cecf6bfb906f847ce579c4f7decc702b9b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1032814/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1032814/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27922,27923,53789,53791</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=6713848$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2976810$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taylor, D J</creatorcontrib><creatorcontrib>Brosnan, M J</creatorcontrib><creatorcontrib>Arnold, D L</creatorcontrib><creatorcontrib>Bore, P J</creatorcontrib><creatorcontrib>Styles, P</creatorcontrib><creatorcontrib>Walton, J</creatorcontrib><creatorcontrib>Radda, G K</creatorcontrib><title>Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome</title><title>Journal of neurology, neurosurgery and psychiatry</title><addtitle>J Neurol Neurosurg Psychiatry</addtitle><description>31P Magnetic resonance spectroscopy studies were carried out in vivo on skeletal muscle of a patient with verapamil-responsive, chronic, progressive post-exertional muscle pain. A sister suffered from a similar complaint. The results showed that the muscle: (1) decreased its high energy phosphate content more rapidly than normal during exercise, indicating either increased utilisation or decreased production of ATP; (2) acidified more rapidly than normal during exercise suggesting an increased glycolytic rate; (3) continued in some studies to acidify markedly during the first minute after exercise, indicating that glycolysis remained active into the recovery period; (4) had phosphocreatine and ADP recovery rates consistent with normal rates of oxidative phosphorylation. On the basis of these results, it was proposed that the patient suffers from a defect in Ca2+ handling in the muscle. Subsequently, direct measurement of Ca2+-ATPase activity in the sarcoplasmic reticulum fraction from a muscle biopsy sample showed that the activity of this enzyme was reduced by about 90%.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Calcium-Transporting ATPases - deficiency</subject><subject>Diseases of striated muscles. Neuromuscular diseases</subject><subject>Exercise Test</subject><subject>Humans</subject><subject>Magnetic Resonance Spectroscopy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Muscle Contraction - drug effects</subject><subject>Muscle Cramp - drug therapy</subject><subject>Muscle Cramp - enzymology</subject><subject>Neurology</subject><subject>Physical Exertion</subject><subject>Verapamil - therapeutic use</subject><issn>0022-3050</issn><issn>1468-330X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkUuLFDEUhYMoYzu6diUUKC6U6smj8toIY-N7UJF2cBeSVOKkpyrVJlU6_e9N0U2jbswmHM6Xy7k5ADxEcIkQYWebGLdLiopYogbTW2CBGiZqQuC322ABIcY1gRTeBfdy3sD5CHkCTrDkTCC4AB9WGj-vz9efdXZV63ywwUW7q0KsdLXVY1Fj9SuMV5WOlbtxaQxD1F3VT9l2rhAFzLvYpqF398Edr7vsHhzuU_D19av16m198enNu9X5RW0Io7Q2kgnpJae-hc5rYYSx3lErWmeRddYz442EzIuGW0e5tI3nxbMcYiMNJqfgxX7udjK9a22JmHSntin0Ou3UoIP624nhSn0ffioECRaoKQOeHgak4cfk8qj6kK3rOh3dMGXFBZMMMVHAx_-Am2FKZf-sEOek_C7HslBne8qmIefk_DEKgmpuSc0tKYqKUHNL5cWjPzc48odaiv_k4OtsdeeTjjbkI8Y4IqKZ49V7LOTR3Rxtna4LQjhVHy9X6nL9RfKX76ma-Wd73vSb_2b8DYecuMw</recordid><startdate>19881101</startdate><enddate>19881101</enddate><creator>Taylor, D J</creator><creator>Brosnan, M J</creator><creator>Arnold, D L</creator><creator>Bore, P J</creator><creator>Styles, P</creator><creator>Walton, J</creator><creator>Radda, G K</creator><general>BMJ Publishing Group Ltd</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>19881101</creationdate><title>Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome</title><author>Taylor, D J ; Brosnan, M J ; Arnold, D L ; Bore, P J ; Styles, P ; Walton, J ; Radda, G K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b3655-b9689f975fd0efa8b8bcfe5c8dec1cecf6bfb906f847ce579c4f7decc702b9b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Calcium-Transporting ATPases - deficiency</topic><topic>Diseases of striated muscles. Neuromuscular diseases</topic><topic>Exercise Test</topic><topic>Humans</topic><topic>Magnetic Resonance Spectroscopy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Muscle Contraction - drug effects</topic><topic>Muscle Cramp - drug therapy</topic><topic>Muscle Cramp - enzymology</topic><topic>Neurology</topic><topic>Physical Exertion</topic><topic>Verapamil - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taylor, D J</creatorcontrib><creatorcontrib>Brosnan, M J</creatorcontrib><creatorcontrib>Arnold, D L</creatorcontrib><creatorcontrib>Bore, P J</creatorcontrib><creatorcontrib>Styles, P</creatorcontrib><creatorcontrib>Walton, J</creatorcontrib><creatorcontrib>Radda, G K</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Science Database (ProQuest)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taylor, D J</au><au>Brosnan, M J</au><au>Arnold, D L</au><au>Bore, P J</au><au>Styles, P</au><au>Walton, J</au><au>Radda, G K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><addtitle>J Neurol Neurosurg Psychiatry</addtitle><date>1988-11-01</date><risdate>1988</risdate><volume>51</volume><issue>11</issue><spage>1425</spage><epage>1433</epage><pages>1425-1433</pages><issn>0022-3050</issn><eissn>1468-330X</eissn><coden>JNNPAU</coden><abstract>31P Magnetic resonance spectroscopy studies were carried out in vivo on skeletal muscle of a patient with verapamil-responsive, chronic, progressive post-exertional muscle pain. A sister suffered from a similar complaint. The results showed that the muscle: (1) decreased its high energy phosphate content more rapidly than normal during exercise, indicating either increased utilisation or decreased production of ATP; (2) acidified more rapidly than normal during exercise suggesting an increased glycolytic rate; (3) continued in some studies to acidify markedly during the first minute after exercise, indicating that glycolysis remained active into the recovery period; (4) had phosphocreatine and ADP recovery rates consistent with normal rates of oxidative phosphorylation. On the basis of these results, it was proposed that the patient suffers from a defect in Ca2+ handling in the muscle. Subsequently, direct measurement of Ca2+-ATPase activity in the sarcoplasmic reticulum fraction from a muscle biopsy sample showed that the activity of this enzyme was reduced by about 90%.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd</pub><pmid>2976810</pmid><doi>10.1136/jnnp.51.11.1425</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3050 |
ispartof | Journal of neurology, neurosurgery and psychiatry, 1988-11, Vol.51 (11), p.1425-1433 |
issn | 0022-3050 1468-330X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1032814 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Adult Biological and medical sciences Calcium-Transporting ATPases - deficiency Diseases of striated muscles. Neuromuscular diseases Exercise Test Humans Magnetic Resonance Spectroscopy Male Medical sciences Muscle Contraction - drug effects Muscle Cramp - drug therapy Muscle Cramp - enzymology Neurology Physical Exertion Verapamil - therapeutic use |
title | Ca2+-ATPase deficiency in a patient with an exertional muscle pain syndrome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T13%3A09%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ca2+-ATPase%20deficiency%20in%20a%20patient%20with%20an%20exertional%20muscle%20pain%20syndrome&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=Taylor,%20D%20J&rft.date=1988-11-01&rft.volume=51&rft.issue=11&rft.spage=1425&rft.epage=1433&rft.pages=1425-1433&rft.issn=0022-3050&rft.eissn=1468-330X&rft.coden=JNNPAU&rft_id=info:doi/10.1136/jnnp.51.11.1425&rft_dat=%3Cproquest_pubme%3E78696168%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1773022729&rft_id=info:pmid/2976810&rfr_iscdi=true |